245 related articles for article (PubMed ID: 17348177)
1. Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.
Lacher DA; Thompson TD; Hughes JP; Saraiya M
Adv Data; 2006 Dec; (379):1-12. PubMed ID: 17348177
[TBL] [Abstract][Full Text] [Related]
2. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
[TBL] [Abstract][Full Text] [Related]
3. Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.
Saraiya M; Kottiri BJ; Leadbetter S; Blackman D; Thompson T; McKenna MT; Stallings FL
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2178-82. PubMed ID: 16172229
[TBL] [Abstract][Full Text] [Related]
4. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
6. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
[TBL] [Abstract][Full Text] [Related]
7. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen screening among young men in the United States.
Scales CD; Antonelli J; Curtis LH; Schulman KA; Moul JW
Cancer; 2008 Sep; 113(6):1315-23. PubMed ID: 18696715
[TBL] [Abstract][Full Text] [Related]
9. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
Lam JS; Cheung YK; Benson MC; Goluboff ET
J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
[TBL] [Abstract][Full Text] [Related]
11. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
Ross LE; Berkowitz Z; Ekwueme DU
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
13. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
[TBL] [Abstract][Full Text] [Related]
15. Race/ethnicity, risk perception, and receipt of prostate-specific antigen testing.
Shavers VL; Underwood W; Moser RP
J Natl Med Assoc; 2009 Jul; 101(7):698-704. PubMed ID: 19634591
[TBL] [Abstract][Full Text] [Related]
16. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen concentration in young men: new estimates and review of the literature.
Sutcliffe S; Pakpahan R; Sokoll LJ; Elliott DJ; Nevin RL; Cersovsky SB; Walsh PC; Platz EA
BJU Int; 2012 Dec; 110(11):1627-35. PubMed ID: 22502603
[TBL] [Abstract][Full Text] [Related]
18. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.
Barocas DA; Grubb R; Black A; Penson DF; Fowke JH; Andriole G; Crawford ED
Cancer; 2013 Jun; 119(12):2223-9. PubMed ID: 23559420
[TBL] [Abstract][Full Text] [Related]
19. Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.
Lacher DA; Hughes JP
Clin Chim Acta; 2015 Aug; 448():220-7. PubMed ID: 26093340
[TBL] [Abstract][Full Text] [Related]
20. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]